Akero Therapeutics Company
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Industry:
P4 Medicine
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2017
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
12
Total Funding:
135000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2018
Last Funding Type:
Series B
Register and Claim Ownership